Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcipotriol/Betamethasone Gel vs Tacalcitol in Psoriasis Vulgaris
NCT00670241Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Apr 2008
- Primary completion
- Feb 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of AKP01, betamethasone dipropionate spray 0.05% in Psoriasis vulgaris (PV), sponsored by LEO Pharma. Started Apr 2008; status: completed.
02
Drugs
AKP01betamethasone dipropionate spray 0.05%
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT00670241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00670241.